Unlock stock picks and a broker-level newsfeed that powers Wall Street.
BSE - Delayed Quote INR

Granules India Limited (GRANULES.BO)

Compare
457.20
-34.05
(-6.93%)
At close: 3:46:24 PM GMT+5:30
Loading Chart for GRANULES.BO
  • Previous Close 491.25
  • Open 494.95
  • Bid 456.50 x --
  • Ask --
  • Day's Range 454.00 - 494.95
  • 52 Week Range 382.05 - 724.55
  • Volume 140,368
  • Avg. Volume 53,754
  • Market Cap (intraday) 110.891B
  • Beta (5Y Monthly) 0.23
  • PE Ratio (TTM) 23.15
  • EPS (TTM) 19.75
  • Earnings Date May 13, 2025 - May 17, 2025
  • Forward Dividend & Yield 1.50 (0.31%)
  • Ex-Dividend Date Jul 30, 2024
  • 1y Target Est 646.88

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

www.granulesindia.com

4,057

Full Time Employees

March 31

Fiscal Year Ends

Recent News: GRANULES.BO

View More

Performance Overview: GRANULES.BO

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

GRANULES.BO
22.72%
S&P BSE SENSEX (^BSESN)
3.55%

1-Year Return

GRANULES.BO
3.18%
S&P BSE SENSEX (^BSESN)
1.53%

3-Year Return

GRANULES.BO
46.23%
S&P BSE SENSEX (^BSESN)
24.34%

5-Year Return

GRANULES.BO
228.21%
S&P BSE SENSEX (^BSESN)
173.15%

Compare To: GRANULES.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GRANULES.BO

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    119.15B

  • Enterprise Value

    127.94B

  • Trailing P/E

    24.87

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.69

  • Price/Book (mrq)

    3.48

  • Enterprise Value/Revenue

    2.89

  • Enterprise Value/EBITDA

    13.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.74%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    44.6B

  • Net Income Avi to Common (ttm)

    4.79B

  • Diluted EPS (ttm)

    19.75

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.17B

  • Total Debt/Equity (mrq)

    32.01%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: GRANULES.BO

View More

Company Insights: GRANULES.BO

Research Reports: GRANULES.BO

View More

People Also Watch